First Horizon Corporation’s NeoGenomics NEO Stock Holding History

First Horizon Corporation’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8K	Sell	737 -1,211	-62%	-$11.7K	﹤0.01%	1094
2026 Q1	$14.5K	Sell	1,948 -561	-22%	-$5.9K	﹤0.01%	973
2025 Q4	$29.5K	Buy	2,509 +865	+53%	+$9.33K	﹤0.01%	836
2025 Q3	$12.7K	Buy	+1,644	New	+$11.5K	﹤0.01%	1010
2021 Q2	$1K	Hold	40	–	–	﹤0.01%	1024
2021 Q1	$1K	Hold	40	–	–	﹤0.01%	1005
2020 Q4	$2K	Hold	40	–	–	﹤0.01%	919
2020 Q3	$1K	Buy	+40	New	+$1.49K	﹤0.01%	959

Other funds holding NEO

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

MWM

MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

First Horizon Corporation's NEO Position: Q2 2026 in Review

First Horizon Corporation reduced its NeoGenomics (NEO) stake by 62% in Q2 2026, selling an estimated $11.7K and leaving 737 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

First Horizon Corporation first reported a position in NEO in Q3 2020 and has held it in 8 quarters since. The position peaked at $29.5K in Q4 2025. 59 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

First Horizon Corporation held 737 shares of NeoGenomics worth $10.8K as of Q2 2026.
First Horizon Corporation sold 1,211 NeoGenomics shares in Q2 2026, an estimated $11.7K.
NeoGenomics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1094 holding.
First Horizon Corporation first reported a position in NeoGenomics in Q3 2020 and has held it in 8 quarters since.
First Horizon Corporation's NeoGenomics position peaked at $29.5K in Q4 2025.
59 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.